Blueprint Medicines to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023

Rhea-AI Summary

Blueprint Medicines Corporation will host a conference call on August 2, 2023, to report its Q2 financial results and provide a corporate update.

Positive

• Investors can access the live conference call and webcast to stay updated on Blueprint Medicines' financial performance and corporate developments.

Negative

• No negative takes available.

CAMBRIDGE, Mass., July 19, 2023 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, August 2, 2023, to report its second quarter financial results and provide a corporate update.

To access the live conference call, please dial 833-470-1428 (domestic) or 404-975-4839 (international), and refer to conference ID 669158. A webcast of the call will also be available under "Events and Presentations" in the Investors & Media section of the Blueprint Medicines website at http://ir.blueprintmedicines.com/. The archived webcast will be available on Blueprint Medicines' website approximately two hours after the conference call and will be available for 30 days following the call.

About Blueprint Medicines

Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy. For more information, visit www.BlueprintMedicines.com and follow us on Twitter (@BlueprintMeds) and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-to-report-second-quarter-2023-financial-results-on-wednesday-august-2-2023-301878911.html

SOURCE Blueprint Medicines Corporation

FAQ

When will Blueprint Medicines host the conference call?

Blueprint Medicines will host the conference call on August 2, 2023.

What will be discussed during the conference call?

The conference call will cover Blueprint Medicines' Q2 financial results and provide a corporate update.

How can investors access the conference call?

Investors can access the live conference call by dialing 833-470-1428 (domestic) or 404-975-4839 (international) and referring to conference ID 669158.

Where can the webcast of the call be found?

The webcast will be available under 'Events and Presentations' in the Investors & Media section of the Blueprint Medicines website.